10x Genomics Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, 10x Genomics stock has a consensus rating of "Buy" and an average price target of $25.23. The average 1-year stock price forecast is 6.55% higher than the current stock price, while the lowest is $20 (-15.54%) and the highest is $32 (+35.14%).

Price Target: $25.23 (+6.55%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$20	$25.23	$25	$32
Change	-15.54%	+6.55%	+5.57%	+35.14%

Analyst Ratings

The average analyst rating for 10x Genomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	2
Buy	2	2	2	3	3	2
Hold	8	9	9	9	9	8
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	0
Total	13	14	14	15	15	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tejas Savant Morgan Stanley	Morgan Stanley	Hold Maintains $20 → $22	Hold	Maintains	$20 → $22	-7.09%	May 12, 2026
Casey Woodring JP Morgan	JP Morgan	Hold Maintains $17 → $20	Hold	Maintains	$17 → $20	-15.54%	May 12, 2026
Kyle Mikson Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $22 → $32	Strong Buy	Maintains	$22 → $32	+35.14%	Apr 20, 2026
Derik De Bruin B of A Securities	B of A Securities	Hold Maintains $21 → $30	Hold	Maintains	$21 → $30	+26.69%	Apr 20, 2026
Luke Sergott Barclays	Barclays	Buy Maintains $22 → $30	Buy	Maintains	$22 → $30	+26.69%	Apr 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

619.06M

from 642.82M

-3.70%

from 642.82M

Revenue Next Year

673.69M

from 619.06M

8.82%

from 619.06M

EPS This Year

-0.83

from -0.35

EPS Next Year

-0.77

from -0.83

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	490.49M	516.41M	618.73M	610.79M	642.82M	619.06M	673.69M
Revenue Growth	64.13%	5.28%	19.81%	-1.28%	5.24%	-3.70%	8.82%
EPS	-0.53	-1.46	-2.18	-1.52	-0.35	-0.83	-0.77
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	17	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	649.3M	742.4M
Avg	619.1M	673.7M
Low	593.3M	628.7M

Revenue Growth

Revenue Growth	2026	2027
High	1.0%	19.9%
Avg	-3.7%	8.8%
Low	-7.7%	1.6%

EPS Forecast

EPS	2026	2027
High	-0.54	-0.35
Avg	-0.83	-0.77
Low	-1.06	-1.08

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.